Clinical Trial Detail

NCT ID NCT02470585
Title Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Subjects With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors AbbVie
Indications

ovarian carcinoma

peritoneal carcinoma

fallopian tube carcinoma

Therapies

Carboplatin

Paclitaxel

Veliparib

Age Groups: adult

No variant requirements are available.